238 related articles for article (PubMed ID: 32827577)
21. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
Han W; Liu J
Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
23. The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets.
Liu J; Pan Y; Liu Y; Wei W; Hu X; Xin W; Chen N
J Cell Physiol; 2023 Aug; 238(8):1693-1715. PubMed ID: 37334436
[TBL] [Abstract][Full Text] [Related]
24. miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.
Gao Y; Luo LH; Li S; Yang C
Biochem Biophys Res Commun; 2014 Feb; 444(2):230-4. PubMed ID: 24462867
[TBL] [Abstract][Full Text] [Related]
25. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.
Lv C; Hao Y; Tu G
Tumour Biol; 2016 Jul; 37(7):9333-42. PubMed ID: 26779632
[TBL] [Abstract][Full Text] [Related]
27. PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.
Sun C; Li S
J Cell Mol Med; 2021 Apr; 25(7):3175-3181. PubMed ID: 33675132
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-214 regulates osteosarcoma survival and growth by directly targeting phosphatase and tensin homolog.
Wang X; Sun J; Fu C; Wang D; Bi Z
Mol Med Rep; 2014 Dec; 10(6):3073-9. PubMed ID: 25310480
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
31. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
32. MiR‑214 promotes osteosarcoma tumor growth and metastasis by decreasing the expression of PTEN.
Liu CJ; Yu KL; Liu GL; Tian DH
Mol Med Rep; 2015 Oct; 12(4):6261-6. PubMed ID: 26252022
[TBL] [Abstract][Full Text] [Related]
33. The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.
Turnham DJ; Bullock N; Dass MS; Staffurth JN; Pearson HB
Cells; 2020 Oct; 9(11):. PubMed ID: 33105713
[TBL] [Abstract][Full Text] [Related]
34. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
35. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
Wang X; Huang H; Young KH
Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
37. Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway.
Tian DD; Zhang RX; Wu N; Yuan W; Luo SH; Chen HQ; Liu Y; Wang Y; He BC; Deng ZL
Oncol Rep; 2017 May; 37(5):2795-2802. PubMed ID: 28393256
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic alterations in osteosarcoma: promising targets.
Li B; Ye Z
Mol Biol Rep; 2014 May; 41(5):3303-15. PubMed ID: 24500341
[TBL] [Abstract][Full Text] [Related]
40. The functions and regulation of the PTEN tumour suppressor.
Song MS; Salmena L; Pandolfi PP
Nat Rev Mol Cell Biol; 2012 Apr; 13(5):283-96. PubMed ID: 22473468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
